[Method for evaluating the efficiency of treatment of urogenital tuberculosis].


Journal

Urologiia (Moscow, Russia : 1999)
ISSN: 1728-2985
Titre abrégé: Urologiia
Pays: Russia (Federation)
ID NLM: 100900900

Informations de publication

Date de publication:
Sep 2020
Historique:
entrez: 8 9 2020
pubmed: 9 9 2020
medline: 18 9 2020
Statut: ppublish

Résumé

Methods for evaluating the efficiency of treatment which were developed for pulmonary tuberculosis (absence of bacterial transmission and closure of cavities) are not suitable for urogenital tuberculosis. To evaluate the use of scoring system for assessing the efficiency of treatment of urogenital tuberculosis. A pilot simple open-label prospective noncomparative cohort study was carried out, which included 15 patients with urogenital tuberculosis. All patients completed the urogenital tuberculosis score upon admission and after 1 month, along with standard clinical, laboratory and X-ray examinations. We developed this score to objectify evaluate the efficiency of antituberculosis therapy and it includes clinical and laboratory manifestations of urogenital tuberculosis. Eleven (73.3%) patients responded well to standard therapy, and 4 (26.7%) required therapy correction. Considering that the correction of therapy was carried out in a timely manner, the final result of the treatment was satisfactory. The efficiency of the proposed score has been demonstrated by clinical results. Using the urogenital tuberculosis score for assessing the results of treatment of urogenital tuberculosis allows timely correction of therapy according to objective criteria.

Identifiants

pubmed: 32897007

Substances chimiques

Antitubercular Agents 0

Types de publication

Journal Article

Langues

rus

Sous-ensembles de citation

IM

Pagination

10-13

Auteurs

S Yu Shevchenko (SY)

TB Research Institute of Ministry of Health of Russia, Novosibirsk, Russia.
FGBOU VO Novosibirsk State Medical University of Ministry of Health of Russia, Novosibirsk, Russia.

E V Kulchavenya (EV)

TB Research Institute of Ministry of Health of Russia, Novosibirsk, Russia.
FGBOU VO Novosibirsk State Medical University of Ministry of Health of Russia, Novosibirsk, Russia.

D P Kholtobin (DP)

TB Research Institute of Ministry of Health of Russia, Novosibirsk, Russia.
FGBOU VO Novosibirsk State Medical University of Ministry of Health of Russia, Novosibirsk, Russia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH